DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

NCT03329690 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm, Gastrointestinal

Interventions

DRUG: DS-8201a
DRUG: Physician's Choice

Sponsor

Daiichi Sankyo Co., Ltd.

Collaborators

[object Object]